1 completed. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Completed 1 |
Follow Wouter H. van Geffen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single Dose Ultibro Breezhaler by Sd-DPI Versus Ipratropium/Salbutamol by Nebulizer in COPD indacaterol/glycopyrronium 110/50 Breezhaler®, Placebo by Breezhaler®, ipratropium/salbutamol 0,5 mg, 2,5 mg by nebulisation - COPD | Phase 4 | Completed | Wouter H. van Geffen | 40 | 2015-12-01 | 2017-10-11 |
Dyspnea (1) · Pulmonary Disease, Chronic Obstructive (1)
Albuterol, Ipratropium Drug Combination (1) · Ipratropium (1) · indacaterol (1)
Netherlands (1)
Huib AM Kerstjens, prof. dr. (1) · Wouter H van Geffen, MD (1)